Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Devlin

Showing results (761-770 of 803) with videos related to

Pageof 81
Sort By:
British Journal of Haematology|May 12, 2024
Atrial arrhythmias following CAR-chimeric antigen receptor T-cell therapy: Incidence, risk factors and biomarker profileRoni Shouval, Adam Goldman, Jessica R Flynn, et al.
Haematologica|June 20, 2024
Anti-CD19 chimeric antigen receptor T-cell therapy has less efficacy in Richter transformation than in <I>de novo</I> large B-cell lymphoma and transformed low-grade B-cell lymphomaOhad Benjamini, Shalev Fried, Roni Shouval, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2021
Impact of <i>TP53</i> Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell TherapyRoni Shouval, Ana Alarcon Tomas, Joshua A Fein, et al.
Haematologica|December 8, 2018
Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemiaWenbin Xiao, Aaron D Goldberg, Christopher A Famulare, et al.
Haematologica|February 22, 2020
Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphomaRichard J Lin, Stephanie M Lobaugh, Martina Pennisi, et al.
Blood|January 21, 2022
Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplantOriana Miltiadous, Nicholas R Waters, Hana Andrlová, et al.
Leukemia & Lymphoma|April 2, 2020
The geriatric syndrome of sarcopenia impacts allogeneic hematopoietic cell transplantation outcomes in older lymphoma patientsRichard J Lin, Laure Michaud, Stephanie M Lobaugh, et al.
Journal of Hematology & Oncology|April 22, 2024
Conventional and novel [<sup>18</sup>F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphomaDoris Leithner, Jessica R Flynn, Sean M Devlin, et al.
Blood Advances|April 20, 2023
Prospective geriatric assessment and geriatric consultation in CAR T-cell therapy for older patients with lymphomaRichard J Lin, Soo Jung Kim, Samantha Brown, et al.
The Journal of Clinical Investigation|September 8, 2020
Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantationGunjan L Shah, Susan DeWolf, Yeon Joo Lee, et al.
Pageof 81

Showing results (761-770 of 803) with videos related to

Sort By:
Pageof 81
British Journal of Haematology|May 12, 2024
Atrial arrhythmias following CAR-chimeric antigen receptor T-cell therapy: Incidence, risk factors and biomarker profileRoni Shouval, Adam Goldman, Jessica R Flynn, et al.
Haematologica|June 20, 2024
Anti-CD19 chimeric antigen receptor T-cell therapy has less efficacy in Richter transformation than in <I>de novo</I> large B-cell lymphoma and transformed low-grade B-cell lymphomaOhad Benjamini, Shalev Fried, Roni Shouval, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2021
Impact of <i>TP53</i> Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell TherapyRoni Shouval, Ana Alarcon Tomas, Joshua A Fein, et al.
Haematologica|December 8, 2018
Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemiaWenbin Xiao, Aaron D Goldberg, Christopher A Famulare, et al.
Haematologica|February 22, 2020
Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphomaRichard J Lin, Stephanie M Lobaugh, Martina Pennisi, et al.
Blood|January 21, 2022
Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplantOriana Miltiadous, Nicholas R Waters, Hana Andrlová, et al.
Leukemia & Lymphoma|April 2, 2020
The geriatric syndrome of sarcopenia impacts allogeneic hematopoietic cell transplantation outcomes in older lymphoma patientsRichard J Lin, Laure Michaud, Stephanie M Lobaugh, et al.
Journal of Hematology & Oncology|April 22, 2024
Conventional and novel [<sup>18</sup>F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphomaDoris Leithner, Jessica R Flynn, Sean M Devlin, et al.
Blood Advances|April 20, 2023
Prospective geriatric assessment and geriatric consultation in CAR T-cell therapy for older patients with lymphomaRichard J Lin, Soo Jung Kim, Samantha Brown, et al.
The Journal of Clinical Investigation|September 8, 2020
Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantationGunjan L Shah, Susan DeWolf, Yeon Joo Lee, et al.
Pageof 81